CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) — FDA Approval ANDA077629 (CHARTWELL MOLECULAR)
CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) — FDA Approval ANDA077629 (CHARTWELL MOLECULAR) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CITALOPRAM HYDROBROMIDE; Active ingredients: CITALOPRAM HYDROBROMIDE; Application number: ANDA077629.
| Brand name | CITALOPRAM HYDROBROMIDE |
|---|---|
| Active ingredients | CITALOPRAM HYDROBROMIDE |
| Application number | ANDA077629 |
| Sponsor | CHARTWELL MOLECULAR |
| Dosage form | SOLUTION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20060614 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →